Huajian Medical’s establishment of IVD GROUP in New York marks a strategic move toward stablecoin licensing and global compliance efforts.
Huajian Medical has announced the formation of its wholly-owned subsidiary IVD GROUP in New York, tasked with overseeing the IVDNewCo Exchange strategy. The subsidiary has commenced the application process for stablecoin licenses with U.S. regulatory bodies, including the SEC and CFTC, advancing the group's global compliance strategy. This initiative follows the company's earlier announcement regarding its US stablecoin license application plan, reflecting its commitment to regulatory compliance in the digital asset space.